Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
07/2003
07/17/2003CA2471880A1 1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor
07/17/2003CA2471868A1 Methods of generating multispecific, multivalent agents from vh and vl domains
07/17/2003CA2471846A1 Pharmaceutical compositions comprising a multifunctional phosphodiesterase inhibitor and an adenosine uptake inhibitor
07/17/2003CA2471752A1 Carboxamidine derivatives and their use in the treatment of vascular diseases
07/17/2003CA2471566A1 Combination of mtp inhibitors or apob-secretion inhibitors with fibrates for use as pharmaceuticals
07/17/2003CA2471204A1 Inhibitors of dipeptidyl peptidase iv
07/17/2003CA2469480A1 Use of biomolecular targets in the treatment and visualization of tumors
07/17/2003CA2469162A1 Composition inhibiting matrix-metallproteinases for the treatmentof neoplastic diseases
07/17/2003CA2468700A1 Extended glucagon-like peptide-1 analogs
07/16/2003EP1327630A1 New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication
07/16/2003EP1327449A1 Remedies for ischemic diseases
07/16/2003EP1326971A2 Proteins and nucleic acids encoding same
07/16/2003EP1326869A1 Pyrrole-condensed morphinoid derivatives
07/16/2003EP1326868A1 Morphinoid derivatives as delta-opioid agonists and antagonists
07/16/2003EP1326867A2 Bridged piperazine derivatives
07/16/2003EP1326864A2 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents
07/16/2003EP1326861A1 Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists
07/16/2003EP1326859A1 Quinazoline derivatives with anti-tumour activity
07/16/2003EP1326858A2 Piperidine compounds as anti-allergic
07/16/2003EP1326856A1 Pyridine derivatives with ikb-kinase (ikk-beta) inhibiting activity
07/16/2003EP1326848A1 Dihydropyrimidine derivatives as cysteine protease inhibitors
07/16/2003EP1326847A1 (2s)-2-(adamantan-1-ylmethoxycarbonylamino)-3-(4-(2-(1,4,5,6-tetrahydropyrimidin-2-ylcarbamoyl)ethyl)benzoylamino)propionic acid isopropyl ester, its preparation and its use
07/16/2003EP1326841A1 Pyridinone derivatives for treatment of atherosclerosis
07/16/2003EP1326838A1 Novel crystalline forms of a factor xa inhibitor
07/16/2003EP1326835A1 Benzamide compounds as apo b secretion inhibitors
07/16/2003EP1326828A1 Beta-amino acid derivatives as integrin receptor antagonists
07/16/2003EP1326822A2 Ketone compounds and compositions for cholesterol management and related uses
07/16/2003EP1326649A1 Tissue-specific exogenous optical agents
07/16/2003EP1326642A2 Catecholamine pharmaceutical compositions and methods
07/16/2003EP1326630A2 Use of glp-1 and glp-2 peptides
07/16/2003EP1326619A2 Pyrrolidine modulators of ccr5 chemokine receptor activity
07/16/2003EP1326615A1 Phosphoric acid salt of an integrin receptor antagonist
07/16/2003EP1326613A1 Use of substituted imidazo 1,2-a]pyridine-, imidazo 1,2-a]pyrimidine and imidazo 1,2-a]pyrazine-3-yl-amine derivatives for producing nos-inhibiting medicaments
07/16/2003EP1326606A2 Ep4 receptor inhibitors to treat rheumatoid arthritis
07/16/2003EP1326604A2 Combination of at least two compounds selected from an at1-receptorantagonist or an ace inhibitor or a hmg-co-a reductase inhibitor groups
07/16/2003EP1326603A1 Composition comprising a catalyst for the dismutation of superoxide and use of the composition for preventing and treating hypotension
07/16/2003EP1326593A1 ESTROGEN RECEPTOR-$g(b) LIGANDS
07/16/2003EP1326591A2 Combination of statins and sorbitol dehydrogenase inhibitors
07/16/2003EP1326531A2 Radioactive emission detector equipped with a position tracking system and utilization thereof with medical systems and in medical procedures
07/16/2003EP1284733A4 Novel processes for preparing torsemide intermediate
07/16/2003EP1191947A4 Methods for treating avm' using radioactive compositions
07/16/2003EP1155000B1 2-aminopyridines containing fused ring substituents
07/16/2003EP1084104B1 Nitric oxide synthase inhibitors
07/16/2003EP1076558B1 2-phenyl-1-[-(2-aminoethoxy)-benzyl -indole in combination with estrogens
07/16/2003EP1070069B1 Bicyclic hydroxamic acid derivatives
07/16/2003EP1054669B1 Use of thiadiazolo[4,3-a]pyridine derivatives
07/16/2003EP1028955B1 Pyrimidinone compounds and pharmaceutical compositions containing them
07/16/2003EP1017385B1 USE OF 4-SUBSTITUTED TETRAHYDROPYRIDINES FOR MAKING MEDICINES ACTING ON TGF-beta 1
07/16/2003EP0832076B1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
07/16/2003CN1430675A Use of baculovirus vectors in gene therapy
07/16/2003CN1430625A 3-nitrogen-6,7-dioxygen steroids and uses thereof
07/16/2003CN1430615A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
07/16/2003CN1430614A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
07/16/2003CN1430612A Hete rocyclic derivatives
07/16/2003CN1430611A 1,4-diazepan-2,5-dione derivatives and their use as NK-1 receptor antagonists
07/16/2003CN1430610A Substituted 1-aminoalkyl-lactams compound and their use as muscarinic receptor antagonists
07/16/2003CN1430607A Benzophenones as inhibitors of IL-1 beta and TNF-alpha
07/16/2003CN1430599A Phenylglycine derivatives
07/16/2003CN1430597A Novel MMP-2/MMP-9 inhibitors
07/16/2003CN1430519A Combinations of enzyme inhibitor-containing preparations and the use thereof
07/16/2003CN1430510A Novel formulations of alpha 2,4-disulforphenyl-N-tert-butylnitrone
07/16/2003CN1430505A Microspheres for active embolization
07/16/2003CN1429945A Toilet paper for anal fistula disease
07/16/2003CN1429835A Preparation method of N-carboxyalkyl dipeptide type angiotensin converting enzyme inhibitor
07/16/2003CN1429830A Water-soluble safflower extract and its oral preparation for treating and preventing angiocardiopathy andcerebrova scular disease
07/16/2003CN1429824A New compound separated from safflower, its preparation method and medical use
07/16/2003CN1429623A Method for treating endothelium wond
07/16/2003CN1429622A Radix rhodiolae double action lozenge
07/16/2003CN1429618A Erigeron breviscapus oral caving fast disintegration tablet and its preparation method
07/16/2003CN1429614A Preparation method of fresh gastrodia whole powder
07/16/2003CN1429589A Medicine for treating hypertension
07/16/2003CN1429587A Ginkgo leaf compound preparation for improving cardiovascular and cerebrovascular blood supply
07/16/2003CN1429576A Edible fungus formula for treating hypertension and diabetes and its preparation method
07/16/2003CN1429557A Chinese medicinal preparation containing lilyturf root polysaccharide and its preparation method
07/16/2003CN1429556A Muscle strong agent and anti-inflammatory agent
07/16/2003CN1429548A Medicine for treating disease related to low cyclo GMP level
07/16/2003CN1429547A Coronary artery skeleton medicinal coating for preventing restenosis of blood vessel
07/16/2003CN1429546A Application of 4-methyl cyclopentadecanone in manufacture of medicine
07/16/2003CN1429502A Pueraria root beverage
07/16/2003CN1114690C Papilloma pseudovirus and process for preparing same
07/16/2003CN1114604C Bicyclic aryl carboxamides and their therapeutic use
07/16/2003CN1114597C Quinoline derivs
07/16/2003CN1114427C Tablet for treating hypertension, cardio-cerebral angiopathy and its preparation method
07/16/2003CN1114425C Chinese patent medicine for treating coronary heart disease and hypertension
07/16/2003CN1114424C Compound artemisia preparation for treating piles and its preparing process
07/16/2003CN1114409C Injection for curing hemoryhoid complicated by anal fistula and its preparation method
07/16/2003CN1114403C Vitronectin receptor antagonists
07/16/2003CN1114402C Isothiazolones compound, preparation containing them and its use
07/15/2003US6593472 NK-1 receptor active amine oxide prodrugs
07/15/2003US6593357 Treating disease states in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, and cardiovascular disease.
07/15/2003US6593352 2-phenylalkylaminobenzoic acid containing substituted benzylsufamoyl group; useful for treating cardiovascular disorders, and for preserving or storing a transplant for surgery
07/15/2003US6593351 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use
07/15/2003US6593350 For therapy of depression, obsessive compulsive disorder, panic attacks, generalized anxiety disorder, social anxiety disorder, sexual dysfunction, eating disorders, obesity, addictive disorders caused by ethanol or cocaine abuse
07/15/2003US6593347 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use
07/15/2003US6593335 Disease than can be ameliorated with a potassium channel opener in a host mammal, comprising administering to the mammal in need thereof a therapeutically effective amount of the compound of claim 1; said disease is epilepsy, Raynaud's
07/15/2003US6593333 Substituted anilino-quinazoline (or quinoline) compounds and use thereof
07/15/2003US6593329 Levosimendan, or (-)-((4-(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)phenyl)hydrazono) -propanedinitrile, which has been previously suggested for the treatment of congestive heart failure is useful in the treatment or prevention of coronary
07/15/2003US6593327 Compounds and compositions as protease inhibitors
07/15/2003US6593326 Useful as anti-cancer agents; and processes for their manufacture and pharmaceutical compositions containing them are described. Apoptotic effect in a warm-blooded animal such as man.
07/15/2003US6593325 Method for the treatment of anxiety which comprises administering to a patient in need of such treatment an effective amount of the compound of claim 1 or a pharmaceutically acceptable salt thereof.
1 ... 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 ... 1595